The drug threat to weight loss supplements
This content item was originally published on www.nutraingredients.com, a William Reed online publication.
Robinson Pharma marketing vice president, Kenn Israel, discusses the recent GlaxoSmithKline petition for weight loss claims be treated as disease claims, and the potential impact of this on the dietary supplement market.
Robinson Pharma marketing vice president, Kenn Israel, discusses the recent GlaxoSmithKline petition for weight loss claims be treated as disease claims, and the potential impact of this on the dietary supplement market.
